MERCK & CO NEWS
Merck & Co., Inc. or Merck Sharp and Dohme (as it is known outside the USA and Canada) is a US pharmaceutical company. It was originally the US subsidiary of the German company, Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during First World War and set up as an independent company. It is now one of the top 5 largest pharmaceutical companies in the world both by capital and revenue.
Alternative To Open Back Surgery - Sponsored Link
Wed, 23 Jul 2008 20:06:00 GMT
Ad - World Leader of Arthroscopic Procedures for Back and Neck Conditions!
[read
more...]
Merck Serono Receives European Approval For Broader Usage Of Erbitux In Metastatic Colorectal Cancer Including 1st-Line Treatment
Wed, 23 Jul 2008 20:06:00 GMT
Extract not available.
[read
more...]
Critical Outcome Technologies Inc. Reports Financial Results for the Fourth Quarter and the Year Ended April 30, 2008
Wed, 23 Jul 2008 20:02:00 GMT
Critical Outcome Technologies Inc. (TSXV:COT) today announced its financial results for the fourth quarter and the year ended April 30, 2008. 'Critical Outcome Technologies Inc. (COTI) has made substantial progress in its first full year of operations as
[read
more...]
HIV vacccine trial cancelled because of safety concerns
Wed, 23 Jul 2008 19:54:00 GMT
A research trial for the PAVE-100 AIDS vaccine planned in the U.S. has been cancelled over concerns that additional research is needed to prove the vaccine is safe before it is tested on a large number of human subjects. A similar vaccine from Merck was
[read
more...]
Critical Outcome Technologies Inc. Reports Financial Results for the Fourth Quarter and the Year Ended April 30, 2008
Wed, 23 Jul 2008 19:30:00 GMT
Critical Outcome Technologies Inc. Reports Financial Results for the Fourth Quarter and the Year Ended April 30, 2008Jul 23, 2008 - 14:57 LONDON (Marketwire) - Critical Outcome Technologies Inc. (TSX VENTURE:COT) today announced its financial results for
[read
more...]
AP Health NewsBrief at 2:51 p.m. EDT
Wed, 23 Jul 2008 19:24:00 GMT
Foreign-born TB cases need better control, US says CHICAGO (AP), Tuberculosis cases continue to fall in the United States, but some immigrants have disturbingly high rates of the disease, according to a study released Tuesday that called for more
[read
more...]
Critical Outcome Technologies Inc. Reports Financial Results for the Fourth Quarter and the Year Ended April 30, 2008
Wed, 23 Jul 2008 19:19:00 GMT
LONDON, ONTARIO, July 23 / MARKET WIRE/ -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) today announced its financial results for the fourth quarter and the year ended April 30, 2008. 'Critical Outcome Technologies Inc. (COTI) has made
[read
more...]
AP Health NewsBrief at 2:59 p.m. EDT
Wed, 23 Jul 2008 19:17:00 GMT
NEW YORK (AP), Microsoft founder Bill Gates and New York Mayor Michael Bloomberg are pooling their piles of money to pour $375 million into a global effort to cut smoking. The billionaire philanthropists, who have a combined worth of more than $70
[read
more...]
Critical Outcome Technologies Inc. Reports Financial Results for the Fourth Quarter and the Year Ended April 30, 2008
Wed, 23 Jul 2008 19:16:00 GMT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) today announced its financial results for the fourth quarter and the year ended April 30, 2008. 'Critical Outcome Technologies Inc. (COTI) has made substantial progress in its first full year of
[read
more...]
Critical Outcome Technologies Inc. Reports Financial Results for the Fourth Quarter and the Year Ended April 30, 2008
Wed, 23 Jul 2008 19:14:00 GMT
(Marketwire Via Acquire Media NewsEdge) LONDON, ONTARIO, July 23 / MARKET WIRE/ -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) today announced its financial results for the fourth quarter and the year ended April 30, 2008. 'Critical Outcome
[read
more...]
Targeting the Interplay of Obesity, Insulin Resistance and Mixed Dyslipidemia: An Integrative Approach to Reducing Cardiometabolic Risk
Wed, 23 Jul 2008 19:10:00 GMT
" symposium held at the Hilton San Francisco in San Francisco, California, on June 9, 2008.Contents of This CME ActivityRobert H. Eckel, MDAvailable As: Henry N. Ginsberg, MDAvailable As: Samuel Klein, MDAvailable As: Jay W. Heinecke, MDAvailable As:
[read
more...]
Critical Outcome Technologies Inc. Reports Financial Results for the Fourth Quarter and the Year Ended April 30, 2008
Wed, 23 Jul 2008 19:06:00 GMT
-- Critical Outcome Technologies Inc. (CDNX:COT.V - News) today announced its financial results for the fourth quarter and the year ended April 30, 2008. 'Critical Outcome Technologies Inc. (COTI) has made substantial progress in its first full year of
[read
more...]
Merck's magic act loses dazzle
Wed, 23 Jul 2008 17:22:00 GMT
By Ransdell Pierson NEW YORK (Reuters) - The glory is quickly fading for drugmaker Merck & Co which dazzled investors over the past three years by recovering from a crisis over its Vioxx painkiller and rolling out blockbuster products. For now the stock
[read
more...]
Merck & Co and S-P shares fall as Vytorin misses primary endpoint in SEAS study
Wed, 23 Jul 2008 17:19:00 GMT
There were sharp drops in the share prices of US drug majors Merck & Co and Schering-Plough after their controversial cholesterol drug Vytorin (ezetimibe and high-dose simvastatin) failed to benefit patients with a rare heart valve disorder. On the day
[read
more...]
$300m shot in the arm for Merck's vaccines plant
Wed, 23 Jul 2008 17:17:00 GMT
Extract not available.
[read
more...]
Q2/2008: Merck Operating Result Increases 1 5% to ' 321 Million
Wed, 23 Jul 2008 17:16:00 GMT
Extract not available.
[read
more...]
Merck Serono Receives European Approval for Broader Usage of Erbitux in Metastatic Colorectal Cancer including 1st-Line Treatment
Wed, 23 Jul 2008 17:16:00 GMT
Extract not available.
[read
more...]
AP Health NewsBrief at 12:42 p.m. EDT
Wed, 23 Jul 2008 17:12:00 GMT
Foreign-born TB cases need better control, US says CHICAGO (AP), Tuberculosis cases continue to fall in the United States, but some immigrants have disturbingly high rates of the disease, according to a study released Tuesday that called for more
[read
more...]
New Report Estimates That South Africa Pharmaceuticals and Healthcare Market Was Worth US$3.03bn in 2007 and Should Reach US$4.41bn By 2012
Wed, 23 Jul 2008 17:07:00 GMT
Author : RESEARCH-AND-MARKETS Category : Press Release News Alerts by Email ( click here ) Press Release News | Home DUBLIN, Ireland - (Business Wire) Research and Markets (http://www.researchandmarkets.com/research/b0eecf/south_africa_pharm) has
[read
more...]
New Report Estimates That South Africa Pharmaceuticals and Healthcare Market Was Worth US$3.03bn in 2007 and Should Reach US$4.41bn By 2012
Wed, 23 Jul 2008 16:49:00 GMT
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b0eecf/south_africa_pharm) has announced the addition of the 'South Africa Pharmaceuticals and Healthcare Report Q3 2008' report to their offering. South
[read
more...]
FDA, CDC back Gardasil shot as safe
Wed, 23 Jul 2008 16:24:00 GMT
WASHINGTON - Merck & Co?€™s Gardasil vaccine remains safe and effective for protecting women and girls from a virus that causes cervical cancer, U.S. officials said on Tuesday after reviewing thousands of reports of health problems.Consumers,
[read
more...]
Merck Serono Receives European Approval for broader usage of Erbitux in Metastatic Colorectal Cancer including 1st-Line Treatment
Wed, 23 Jul 2008 15:44:00 GMT
5957 live jobs on pharmiweb.com now For more information:http://www.globalcancernews.com
[read
more...]
Overview of Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
Wed, 23 Jul 2008 15:11:00 GMT
diabetes Identify the benefits and risks of using exenatide to treat type 2 diabetes Describe treatment with DPP-4 inhibitors for type 2 diabetes Specify research results from early trials of liraglutide Authors and Richard E. Pratley, MD Disclosure:
[read
more...]
NBR Transcripts- Tuesday, July 22, 2008
Wed, 23 Jul 2008 15:04:00 GMT
Washington Mutual & Wachovia's Losses Didn't Slow The Financial Sector's Gains SUSIE GHARIB: Financial stocks soared today, despite huge losses from two big banks: Wachovia and Washington Mutual. First, Washington Mutual -- it reported a much steeper
[read
more...]
Overview of Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
Wed, 23 Jul 2008 14:35:00 GMT
Upon completion of this activity, participants will be able to: Richard E. Pratley, MD Disclosure: Richard E. Pratley, MD, has received research grants and participated in clinical trials for Takeda, GlaxoSmithKline, Novartis, Merck, Lilly, and
[read
more...]
Q2/2008: Merck Operating Result Increases 1 5% to â,¬ 321 Million
Wed, 23 Jul 2008 14:34:00 GMT
Already have a TherapeuticsDaily.com or PharmaLive.com account? Click on the button below to login.
[read
more...]
Schering-Plough Reports Financial Results for Second Quarter of 2008
Wed, 23 Jul 2008 14:25:00 GMT
Broad-Based Performance and Robust Phase III Pipeline Validate Growth and Diversification Strategy; OBS Acquisition Already Contributing to Results KENILWORTH, N.J., July 21, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today reported
[read
more...]
Merck Reports Second-Quarter 2008 Financial Results
Wed, 23 Jul 2008 14:22:00 GMT
- Merck & Co., Inc. today announced financial results for the second quarter of 2008. Merck reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) of $0.86 for the second quarter of 2008, excluding restructuring
[read
more...]
VisEn Medical buoyed by $3.5M
Wed, 23 Jul 2008 14:13:00 GMT
Pharma powerhouses team up with life sciences vets to launch Enlight [July 10, 2008] Cambridge investors pump $13M into Accuri Cytometers [July 8, 2008] VisEn Medical Inc., a maker of fluorescence-imaging products, has reported that it received venture
[read
more...]
Analysts cut Merck target on withheld view; shares fall
Wed, 23 Jul 2008 13:41:00 GMT
BANGALORE (Reuters) - Leerink Swann downgraded Merck & Co Inc, while several other brokerages cut their targets on the stock Tuesday, a day after the drug maker withheld its 2008 earnings forecast after a mostly negative study on cholestrol treatment
[read
more...]
U.S. FDA, CDC say Merck's Gardasil shot remains safe
Wed, 23 Jul 2008 13:35:00 GMT
WASHINGTON (Reuters) - A review of health problems reported after women and girls received Merck & Co's Gardasil vaccine shows it remains safe and effective for protecting against a virus that causes cervical cancer, U.S. officials said on Tuesday. A
[read
more...]
powered by zFeeder
Blogos.net